Forget the SpaceX IPO. Thursday Is Space Earnings Day for Space Stocks BlackSky, Redwire, and Rocket Lab

The article previews Q1 earnings for BlackSky, Redwire, and Rocket Lab, with consensus calling for BlackSky sales of $27.3 million and a $0.40/share loss, Redwire sales of $104.6 million and a $0.17/share loss, and Rocket Lab sales of $189.4 million and a $0.08/share loss. It frames Rocket Lab as a SpaceX-like growth story and highlights SpaceX's still-pending IPO, but the piece is largely a forward-looking earnings and valuation comparison rather than a major catalyst. Market impact is most likely limited to the individual names around earnings.

Analysis

The immediate setup is less about “space” as a theme and more about dispersion within the group. The market is likely to reward the names with the clearest path to operating leverage and punish those where revenue quality is still too dependent on low-margin or lumpy contract work; that creates a near-term relative-value opportunity even if the sector headline remains constructive. The biggest second-order beneficiary of the SpaceX narrative is actually the broader launch-and-space-systems complex, because it reinforces investor willingness to underwrite longer-duration hardware businesses, but that can also compress differentiation and make execution the only thing that matters.

The earnings window is the real catalyst, not the IPO chatter. Over the next 24 hours, these prints can reprice expectations for the next 1-2 quarters, while the SpaceX IPO is a 1-3 month sentiment driver that may never convert into immediate cash-flow comparables. The key risk is that investors extrapolate one strong guide and one aspirational launch milestone into a straight-line valuation rerating; if any of the names miss on margin or cash burn, the stocks could give back quickly because positioning is likely crowded and enthusiasm is already elevated.

Among the trio, the market appears to be assigning the highest optionality premium to the launch-focused name, but the more durable fundamental setup may be the systems supplier if revenue growth is paired with evidence of integration synergies. The weakest relative setup is the imaging business: better technology does not automatically translate into pricing power if sales growth remains negative and losses widen. The contrarian read is that the SpaceX buzz may actually cap upside in the near term by setting an unreasonably high bar for all public space names, especially if investors start comparing every company to a non-public, capital-advantaged platform rather than to realistic public-market peers.

Key Decisions for Investors

• Go long RKLB into the print only if implied move is still below ~10%: use a defined-risk call spread for 2-4 week upside, because a clean beat-plus-guidance raise could drive a fast multiple expansion; cut if management implies any delay in Neutron commercialization.
• Prefer RDW on a 1-2 quarter horizon as a relative-value long versus BKSY: the business mix has more visible operating leverage, so a revenue beat should translate into a sharper equity reaction than in a lower-growth imaging name.
• Avoid chasing BKSY ahead of earnings; if you want exposure, wait for post-earnings stabilization and look for a downside hedge or a bearish put spread if losses and top-line deterioration persist.
• Pair trade: long RKLB / short BKSY for the next 1-3 months, betting that the market rewards credible path-to-scale and penalizes pure sentiment names with weaker fundamentals.
• If the group spikes on SpaceX IPO headlines, use strength to trim rather than add; the better entry is after earnings volatility, when guidance resets are known and the valuation gap can be underwritten with actual numbers.